Saturday 17 October 2026
Export HQY’s income statement to Excel — free account
HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
92.03
0.48
−0.52%
Follow HQY
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
| 11.43% | 11.06% | 10.19% | 9.01% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 8 | 9 | 9 | |
| 7.07% | 6.86% | 6.30% | 5.57% | ||
ROIC |
8.24% | 7.85% | 7.34% | 6.54% | |
Return on Tangible Assets |
75.98% | 68.95% | 60.01% | 50.29% | |
Average Days of Receivables |
32.74 | 33.30 | 34.37 | 31.46 | |
Free Cash Flow per Share |
5.24 | 5.23 | 4.74 | 4.22 | |
Free Cash Flow |
436.95 | 441.25 | 408.32 | 362.67 | |
Capital Expenditures |
(53.22) | (48.63) | (48.78) | (52.26) | |
| Other line items | |||||
Cash ROIC |
13.75% | 13.55% | 12.07% | 10.59% | |
Accounts Receivable Turnover |
11.67 | 11.23 | 10.87 | 11.84 | |
Accounts Payable Turnover |
43.06 | 28.30 | 30.19 | 27.87 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.01 | 13.24 | 11.09 | 17.13 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.23) | (0.23) | (0.22) | (0.22) | |
Research and Development Expense of Revenue |
20.41% | 20.10% | 19.99% | 19.90% | |
Selling, General and Administrative Expense of Revenue |
16.87% | 16.57% | 16.38% | 16.25% | |
Share Based Compensation of Revenue |
5.97% | 5.84% | 5.56% | 5.86% | |
Interest Coverage |
6.69 | 6.24 | 5.64 | 4.97 | |
Operating CF/Net income |
2.07 | 2.12 | 2.12 | 2.16 | |
Depreciation/Fixed assets |
32.87 | 40.79 | 49.01 | 46.08 | |
Capex/Depreciation |
(0.34) | (0.31) | (0.31) | (0.33) | |
Revenue per Share |
16.34 | 15.84 | 15.25 | 15.01 | |
Operating CF per Share |
5.88 | 5.80 | 5.31 | 4.83 | |
Capex per Share |
(0.64) | (0.58) | (0.57) | (0.61) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 |
Columns are period end dates